Pulmonary Hypertension Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns
Conditions: Persistent Pulmonary Hypertension of the Newborn; Nebulized Nitroglycerine; Echocardiography Interventions: Drug: Nebulized nitroglycerine as adjunctive therapy; Drug: conventional therapy for PPHN Sponsor: Alexandria University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials
The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns
Conditions: Persistent Pulmonary Hypertension of the Newborn; Echocardiography; Respiratory Disease Interventions: Drug: Nebulized nitroglycerine as adjunctive therapy; Drug: conventional therapy for PPHN Sponsor: Alexandria University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials
The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborns
Conditions: Persistent Pulmonary Hypertension of the Newborn; Nebulized Nitroglycerine; Echocardiography Interventions: Drug: Nebulized nitroglycerine as adjunctive therapy; Drug: conventional therapy for PPHN Sponsor: Alexandria University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials
A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2
Conditions: Pulmonary Hypertension (World Health Organization Group 2); Heart Failure Interventions: Drug: AZD3427; Drug: Placebo Sponsors: AstraZeneca; Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials